鼻腔给药
医学
减毒疫苗
病毒学
生物
遗传学
毒力
基因
作者
Olubukola T. Idoko,Sergio L. Vargas,Agustin Bueso,Doris Maribel Rivera,Henderson Edward,Michael W. Simon,Peyman Banooni,S A Berger,Stephane Janicot,Camille Vercasson,Sophie Pallardy,Rapi Nteene,Haritha Adhikarla,Eric Gerchman,Monica Gasparotto,Scott Gallichan,Enrique Rivas,Ursula J. Buchholz,Peter L. Collins,Sanie Sesay
出处
期刊:NEJM evidence
[New England Journal of Medicine]
日期:2025-08-26
卷期号:4 (9): EVIDoa2500026-EVIDoa2500026
被引量:3
标识
DOI:10.1056/evidoa2500026
摘要
The RSVt vaccine demonstrated promising immunogenicity profiles at both LD and HD strengths among infants and toddlers, without identified safety concerns. (Funded by Sanofi; ClinicalTrials.gov number, NCT04491877).
科研通智能强力驱动
Strongly Powered by AbleSci AI